Clinical Trial Update: Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating docetaxel plus carboplatin as second-line treatment for small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Dr. B. Biesma | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED